Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
Acute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure....
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Toxics |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6304/10/11/667 |
_version_ | 1827645420402114560 |
---|---|
author | Mohammed Kaleem Ullah Ashwaghosha Parthasarathi Jayaraj Biligere Siddaiah Prashant Vishwanath Swapna Upadhyay Koustav Ganguly Padukudru Anand Mahesh |
author_facet | Mohammed Kaleem Ullah Ashwaghosha Parthasarathi Jayaraj Biligere Siddaiah Prashant Vishwanath Swapna Upadhyay Koustav Ganguly Padukudru Anand Mahesh |
author_sort | Mohammed Kaleem Ullah |
collection | DOAJ |
description | Acute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure. In our cross-sectional study, conducted between 1 January 2016 to 31 December 2020, the patients were categorized into six groups based on pathology: non-bacterial and non-eosinophilic; bacterial; eosinophilic; bacterial infection with eosinophilia; pneumonia; and bronchiectasis. Further, four groups were classified based on exposure to tobacco smoke (TS), biomass smoke (BMS), both, or no exposure. Cox proportional-hazards regression analyses were performed to assess hazard ratios, and Kaplan–Meier analysis was performed to assess survival, which was then compared using the log-rank test. The odds ratio (OR) and independent predictors of ward admission type and length of hospital stay were assessed using binomial logistic regression analyses. Of the 2236 subjects, 2194 were selected. The median age of the cohort was 67.0 (60.0 to 74.0) and 75.2% were males. Mortality rates were higher in females than in males (6.2% vs. 2.3%). AECOPD-B (bacterial infection) subjects [HR 95% CI 6.42 (3.06–13.46)], followed by AECOPD-P (pneumonia) subjects [HR (95% CI: 4.33 (2.01–9.30)], were at higher mortality risk and had a more extended hospital stay (6.0 (4.0 to 9.5) days; 6.0 (4.0 to 10.0). Subjects with TS and BMS-AECOPD [HR 95% CI 7.24 (1.53–34.29)], followed by BMS-AECOPD [HR 95% CI 5.28 (2.46–11.35)], had higher mortality risk. Different phenotypes have different impacts on AECOPD clinical outcomes. A better understanding of AECOPD phenotypes could contribute to developing an algorithm for the precise management of different phenotypes. |
first_indexed | 2024-03-09T18:35:10Z |
format | Article |
id | doaj.art-5764341914d141b1b764f238bb921858 |
institution | Directory Open Access Journal |
issn | 2305-6304 |
language | English |
last_indexed | 2024-03-09T18:35:10Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Toxics |
spelling | doaj.art-5764341914d141b1b764f238bb9218582023-11-24T07:09:58ZengMDPI AGToxics2305-63042022-11-01101166710.3390/toxics10110667Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional StudyMohammed Kaleem Ullah0Ashwaghosha Parthasarathi1Jayaraj Biligere Siddaiah2Prashant Vishwanath3Swapna Upadhyay4Koustav Ganguly5Padukudru Anand Mahesh6Centre for Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaAllergy, Asthma, and Chest Centre, Krishnamurthypuram, Mysore 570004, Karnataka, IndiaDepartment of Respiratory Medicine, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaCentre for Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaUnit of Integrative Toxicology, Institute of Environmental Medicine (IMM), Karolinska Institutet, 17177 Stockholm, SwedenUnit of Integrative Toxicology, Institute of Environmental Medicine (IMM), Karolinska Institutet, 17177 Stockholm, SwedenDepartment of Respiratory Medicine, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaAcute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure. In our cross-sectional study, conducted between 1 January 2016 to 31 December 2020, the patients were categorized into six groups based on pathology: non-bacterial and non-eosinophilic; bacterial; eosinophilic; bacterial infection with eosinophilia; pneumonia; and bronchiectasis. Further, four groups were classified based on exposure to tobacco smoke (TS), biomass smoke (BMS), both, or no exposure. Cox proportional-hazards regression analyses were performed to assess hazard ratios, and Kaplan–Meier analysis was performed to assess survival, which was then compared using the log-rank test. The odds ratio (OR) and independent predictors of ward admission type and length of hospital stay were assessed using binomial logistic regression analyses. Of the 2236 subjects, 2194 were selected. The median age of the cohort was 67.0 (60.0 to 74.0) and 75.2% were males. Mortality rates were higher in females than in males (6.2% vs. 2.3%). AECOPD-B (bacterial infection) subjects [HR 95% CI 6.42 (3.06–13.46)], followed by AECOPD-P (pneumonia) subjects [HR (95% CI: 4.33 (2.01–9.30)], were at higher mortality risk and had a more extended hospital stay (6.0 (4.0 to 9.5) days; 6.0 (4.0 to 10.0). Subjects with TS and BMS-AECOPD [HR 95% CI 7.24 (1.53–34.29)], followed by BMS-AECOPD [HR 95% CI 5.28 (2.46–11.35)], had higher mortality risk. Different phenotypes have different impacts on AECOPD clinical outcomes. A better understanding of AECOPD phenotypes could contribute to developing an algorithm for the precise management of different phenotypes.https://www.mdpi.com/2305-6304/10/11/667COPDacute exacerbationphenotypeAECOPDbiomasstobacco |
spellingShingle | Mohammed Kaleem Ullah Ashwaghosha Parthasarathi Jayaraj Biligere Siddaiah Prashant Vishwanath Swapna Upadhyay Koustav Ganguly Padukudru Anand Mahesh Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study Toxics COPD acute exacerbation phenotype AECOPD biomass tobacco |
title | Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study |
title_full | Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study |
title_fullStr | Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study |
title_full_unstemmed | Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study |
title_short | Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study |
title_sort | impact of acute exacerbation and its phenotypes on the clinical outcomes of chronic obstructive pulmonary disease in hospitalized patients a cross sectional study |
topic | COPD acute exacerbation phenotype AECOPD biomass tobacco |
url | https://www.mdpi.com/2305-6304/10/11/667 |
work_keys_str_mv | AT mohammedkaleemullah impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT ashwaghoshaparthasarathi impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT jayarajbiligeresiddaiah impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT prashantvishwanath impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT swapnaupadhyay impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT koustavganguly impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy AT padukudruanandmahesh impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy |